These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10406507)

  • 1. Major and minor risk factors for cardiovascular disease in continuous ambulatory peritoneal dialysis patients.
    Prichard S
    Perit Dial Int; 1999; 19 Suppl 2():S133-7. PubMed ID: 10406507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis.
    Lameire N; Bernaert P; Lambert MC; Vijt D
    Kidney Int Suppl; 1994 Dec; 48():S31-8. PubMed ID: 7700039
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular risk in continuous ambulatory peritoneal dialysis patients.
    Culleton B; Parfrey PS
    Perit Dial Int; 1996; 16(1):10-2. PubMed ID: 8616162
    [No Abstract]   [Full Text] [Related]  

  • 4. Should hyperlipidaemia in dialysis patients be treated?
    Wheeler DC
    Nephrol Dial Transplant; 1997 Jan; 12(1):19-21. PubMed ID: 9027766
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular risk factors and blood pressure control in continuous ambulatory peritoneal dialysis.
    Lameire N
    Perit Dial Int; 1993; 13 Suppl 2():S394-5. PubMed ID: 8399620
    [No Abstract]   [Full Text] [Related]  

  • 6. Major and minor risk factors for cardiovascular disease in peritoneal dialysis.
    Prichard S
    Perit Dial Int; 2000; 20 Suppl 2():S154-9. PubMed ID: 10911662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular problems in the choice of dialysis therapy for the elderly.
    Maiorca R
    Contrib Nephrol; 1994; 106():74-83. PubMed ID: 8174382
    [No Abstract]   [Full Text] [Related]  

  • 8. [Abnormality of lipid metabolism in patients on continuous ambulatory peritoneal dialysis (CAPD)].
    Saito E; Matsuda N; Tanahashi Y; Makise J; Kanayama M
    Rinsho Byori; 1986 Sep; 34(9):1083-7. PubMed ID: 3795543
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperhomocysteinemia and oxidative stress during dialysis treatment.
    Chiarello PG; Vannucchi MT; Vannucchi H
    Ren Fail; 2003 Mar; 25(2):203-13. PubMed ID: 12739827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective aspects for atherogenesis and lipid abnormalities in continuous ambulatory peritoneal dialysis patients.
    Nakagawa S; Ozawa K
    Perit Dial Int; 1993; 13 Suppl 2():S418-20. PubMed ID: 8399628
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of symptomatic arterial disease and risk factors for its development in patients on continuous ambulatory peritoneal dialysis.
    Webb AT; Brown EA
    Perit Dial Int; 1993; 13 Suppl 2():S406-8. PubMed ID: 8399624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dyslipidemia in renal failure].
    Fujioka T; Ueno T; Matsumoto T; Watanabe H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():118-23. PubMed ID: 15250280
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperlipemia in CAPD.
    Atkins RC; Wood C
    Perit Dial Int; 1993; 13 Suppl 2():S415-7. PubMed ID: 8399627
    [No Abstract]   [Full Text] [Related]  

  • 14. C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis.
    Paniagua R; Frías Y; de Ventura MJ; Rodríguez E; Hurtado ME; Alcántara G; Vázquez R; Ortiz R; Salcedo M; Rios ME; Kaji J; Amato D
    Perit Dial Int; 2003; 23(2):132-7. PubMed ID: 12713079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease and risk factors in patients treated by continuous ambulatory peritoneal dialysis.
    Maher JF
    Perit Dial Int; 1993; 13 Suppl 2():S383-93. PubMed ID: 8399618
    [No Abstract]   [Full Text] [Related]  

  • 16. [Abnormalities of lipid metabolism in chronic dialysis patients].
    Fujioka T; Saito E; Yasugi T; Shimizu T
    Nihon Rinsho; 1992 Jan; 50 Suppl():527-34. PubMed ID: 1578734
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis.
    Steele J; Billington T; Janus E; Moran J
    Atherosclerosis; 1989 Sep; 79(1):47-50. PubMed ID: 2803346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative morbidity among hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Churchill DN
    Kidney Int Suppl; 1993 Feb; 40():S16-22. PubMed ID: 8445834
    [No Abstract]   [Full Text] [Related]  

  • 19. Peritoneal dialysis in children: issues for the 21st century.
    Salusky IB; Holloway M; Kuizon BD
    Perit Dial Int; 1999; 19 Suppl 2():S484-8. PubMed ID: 10406569
    [No Abstract]   [Full Text] [Related]  

  • 20. Disorders of carbohydrate and lipid metabolism in uremia.
    Bagdade
    Nephron; 1975; 14(2):153-62. PubMed ID: 1093054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.